Green environment of office buildings in science and technology park, Chongqing, China

How the Timing of Director Review May Affect Co-Pending Litigation

Start
Director Review at the Patent Trial and Appeal Board (PTAB) remains a hot topic in patent law. The Director first established an interim process for Director Review in the wake of the Supreme Court’s 2021 decision in United States v. Arthrex, and the USPTO issued a Notice of Proposed Rulemaking, discussed here, that would make Director Review a permanent feature of PTAB trial proceedings….
By: Fish & Richardson
Previous Story

FDA and FTC Issue Joint Warning Letters for Copycat Delta-8 THC Food Products

Next Story

Janssen Pharms., Inc. v. Teva Pharms. USA, Inc. – Invega Sustenna® (Paliperidone Palmitate)